- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Poxel SA (POXEL)
Poxel SA stock price live, this page displays EPA POXEL stock exchange data. View the POXEL premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Poxel SA real time stock price chart below.
What Is the Poxel SA Stock Price Today?
The Poxel SA stock price today is 0.56.
What Is the Stock Symbol for Poxel SA?
The stock symbol for Poxel SA is ""POXEL.""
What Stock Exchange Does Poxel SA Trade On?
Poxel SA is listed and trades on the Paris stock exchange.
Is Poxel SA a Good Stock to Buy?
Determining whether Poxel SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the POXEL quote. (ISIN: FR0012432516)
What Is the Poxel SA Stock Price Today?
The Poxel SA stock price today is 0.56.
What Is the Stock Symbol for Poxel SA?
The stock symbol for Poxel SA is ""POXEL.""
What Stock Exchange Does Poxel SA Trade On?
Poxel SA is listed and trades on the Paris stock exchange.
Is Poxel SA a Good Stock to Buy?
Determining whether Poxel SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the POXEL quote. (ISIN: FR0012432516)
Paris
Currency in EUR
0.56
0.00(0.00%)
Closed·
Fair Value
An estimate of a Poxel SA's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.56
0.56
52 wk Range
0.12
0.83
POXEL Scorecard
Full Analysis
Net income is expected to grow this year
POXEL is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Poxel SA's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.560.56
52 wk Range
0.120.83
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
POXEL Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Poxel SA's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
- Poxel Announces its Financial Calendar for 2025
- Investing.com
- Poxel Announces its Financial Calendar for 2025
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Poxel SA Company Profile
Poxel S.A., a clinical-stage biopharmaceutical company, develops novel treatments for metabolic diseases, type 2 diabetes, and liver diseases. The company’s lead product is TWYMEEG (Imeglimin), an oral drug candidate that targets mitochondrial dysfunction and approved for the treatment of type 2 diabetes in Japan. It also develops PXL770, an adenosine monophosphate-activated protein kinase enzyme, which is in a Phase 2a clinical trial that treats chronic metabolic diseases, including diseases that affect the liver, such as non-alcoholic steatohepatitis (NASH); PXL065, an earlier stage programs that is in Phase 2 for the treatment of NASH focusing on chronic and rare metabolic indications. The company has a licensing agreement with Enyo Pharma S.A.S. for the development of farnesoid X receptor that is in Phase 2a study for the treatment of hepatitis B and NASH; and DeuteRx LLC for the development of PXL065, a mitochondrial dysfunction; and Sumitomo Pharma for development and commercialization of Imeglimin. Poxel S.A. was incorporated in 2009 and is headquartered in Lyon, France.
Compare POXEL to Peers and Sector
Metrics to compare | POXEL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPOXELPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.9x | −2.2x | −0.5x | |
PEG Ratio | −0.02 | 0.02 | 0.00 | |
Price/Book | −0.6x | 1.6x | 2.6x | |
Price / LTM Sales | 14.0x | 3.9x | 3.3x | |
Upside (Analyst Target) | - | 136.1% | 43.4% | |
Fair Value Upside | Unlock | 16.3% | 7.1% | Unlock |
Earnings
Latest Release
May 20, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Stock Exchange Does Poxel SA Trade On?
Poxel SA is listed and trades on the Paris Stock Exchange stock exchange.
What Is the Stock Symbol for Poxel SA?
The stock symbol for Poxel SA is "POXEL."
What Is the Poxel SA Market Cap?
As of today, Poxel SA market cap is 30.06M.
What Is Poxel SA's Earnings Per Share (TTM)?
The Poxel SA EPS (TTM) is -0.41.
When Is the Next Poxel SA Earnings Date?
Poxel SA will release its next earnings report on 05 Nov 2025.
From a Technical Analysis Perspective, Is POXEL a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Poxel SA Stock Split?
Poxel SA has split 0 times.
How Many Employees Does Poxel SA Have?
Poxel SA has 6 employees.
What is the current trading status of Poxel SA (POXEL)?
As of 08 Aug 2025, Poxel SA (POXEL) is trading at a price of 0.56, with a previous close of 0.56. The stock has fluctuated within a day range of 0.56 to 0.56, while its 52-week range spans from 0.12 to 0.83.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.